Century Therapeutics reported cash from operations of -$19.83M and free cash flow of -$20.53M for the quarter ended Jun 2026, up 28.1% year over year. This cash flow statement covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||||
| Net Income | -26.01M | -28.15M | -37.51M | -30.99M | -30.75M | -31.68M | -31.26M | -33.29M | -32.72M | -39.40M | -28.06M | -31.21M | -31.23M | -8.13M | 76.56M | -32.54M | -34.42M | -19.28M | -21.66M | -34.55M | |||||
| Share-based CompensationStock Comp. | 1.22M | 1.64M | 2.38M | 2.77M | 2.79M | 2.73M | 3.80M | 3.29M | 3.98M | 3.56M | 4.91M | 5.12M | 5.36M | 2.66M | 6.63M | 6.82M | 0.89M | 1.30M | 11.58M | 11.46M | |||||
| Asset Writedowns and ImpairmentWritedown | 4.22M | 12.14M | 4.33M | 6.76M | |||||||||||||||||||||
| Cash from OperationsCash from Ops. | -23.98M | -24.35M | 86.75M | -25.56M | -24.24M | -22.91M | -29.22M | -19.25M | -13.65M | -26.23M | -30.25M | -27.33M | -28.33M | -24.22M | -34.62M | -27.59M | -25.58M | -16.10M | -25.26M | -19.83M | |||||
| Depreciation, Depletion & Amortization | |||||||||||||||||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 1.11M | 1.34M | 1.32M | 1.03M | 0.85M | 0.65M | 0.51M | 0.35M | 0.21M | 0.15M | |||||||||||||||
| Amortization of Deferred ChargesAmort. Deferred Charges | 0.08M | 0.08M | 0.08M | 0.08M | 0.08M | 0.07M | 0.06M | 0.04M | |||||||||||||||||
| Change in Working Capital | |||||||||||||||||||||||||
| Change in Account PayablesChange Payables | -0.58M | 2.29M | -1.50M | -2.36M | 0.71M | -1.63M | -2.95M | -0.51M | 3.99M | -2.89M | 0.69M | -1.88M | -0.76M | 0.48M | 0.36M | -0.36M | -0.59M | 2.16M | -1.62M | 1.67M | |||||
| Change in Accured ExpensesChange Accured Exp. | 0.38M | -1.19M | -1.17M | 2.27M | 1.73M | 1.13M | -3.21M | 1.93M | 2.93M | -2.39M | -3.32M | -0.24M | 2.25M | 2.91M | -6.54M | 0.71M | 0.44M | 1.08M | -3.96M | 1.16M | |||||
| Investing Activities | |||||||||||||||||||||||||
| Capital ExpendituresCapex | 15.74M | 16.72M | 4.07M | 10.46M | 9.81M | 6.27M | 4.99M | 4.50M | 3.27M | 0.98M | 0.54M | 0.27M | 0.47M | 0.32M | 0.20M | -0.14M | 0.58M | 0.69M | |||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 14.76M | 38.01M | 63.09M | 57.20M | 98.86M | 52.33M | 79.16M | 110.49M | 64.98M | 29.27M | 47.17M | 29.87M | 51.57M | 48.18M | 43.29M | 42.52M | 35.89M | 37.82M | 28.66M | 34.37M | |||||
| Cash from Investing ActivitiesCash from Investing | -147.05M | -20.60M | -44.04M | 12.52M | 22.66M | -4.27M | 31.34M | 6.97M | 4.22M | 18.60M | 11.54M | -33.86M | 39.20M | 30.61M | 27.93M | 32.54M | 24.67M | 22.36M | -112.61M | 17.77M | |||||
| Financing Activities | |||||||||||||||||||||||||
| Other financing activitiesOther financing | -0.48M | ||||||||||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | -0.47M | 0.11M | 26.88M | 0.05M | 0.14M | 0.10M | 0.45M | -10.12M | 0.30M | -0.36M | 18.20M | 56.70M | 0.27M | -0.60M | 0.12M | 0.05M | 126.62M | 0.31M | |||||||
| Change in Capital Stock | |||||||||||||||||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | 0.21M | 1.87M | 2.55M | 3.77M | 5.18M | 1.43M | 3.02M | 1.49M | 2.05M | 2.99M | |||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 0.07M | 0.05M | 0.14M | 0.10M | 0.45M | 0.12M | 0.30M | -0.36M | 0.37M | 0.10M | 0.27M | -0.60M | 0.12M | 0.05M | 0.20M | 0.35M | |||||||||
| Additional items | |||||||||||||||||||||||||
| Change in Cash | -171.50M | -44.85M | 69.59M | -12.99M | -1.44M | -27.09M | 2.57M | -22.39M | -9.13M | -7.98M | -0.51M | -4.50M | 11.14M | 5.78M | -6.57M | 4.95M | -0.91M | 6.34M | -11.25M | -1.76M | |||||
| Free Cash FlowFCF | -39.72M | -41.07M | 82.69M | -36.01M | -34.05M | -29.18M | -34.21M | -23.75M | -16.91M | -27.21M | -30.79M | -27.60M | -28.33M | -24.22M | -35.10M | -27.91M | -25.78M | -15.96M | -25.85M | -20.53M | |||||
| Net Cash FlowNCF | -171.50M | -44.85M | 69.59M | -12.99M | -1.44M | -27.09M | 2.57M | -22.39M | -9.13M | -7.98M | -0.51M | -4.50M | 11.14M | 5.78M | -6.57M | 4.95M | -0.91M | 6.31M | -11.25M | -1.76M |